Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

62 results about "Lung lesion" patented technology

A lung lesion is abnormal tissue found on or in a person’s lung. It can be the result of an infection or illness, which may clear up without causing the patient long-term problems. It can be the result of an infection or illness, which may clear up without causing the patient long-term problems.

Automatic segmenting method for lesion tissue in lung CT image

ActiveCN104715483ASegment images accuratelyImage analysisParenchymaRadiology
The invention provides an automatic segmenting method for lesion tissue in a lung CT image. The automatic segmenting method comprises the steps that the lung parenchyma CT image is searched for the minimum neighborhood gradient value of all points through a toboggan algorithm, the area of the initial growth point of the lung lesion is obtained according to the minimum neighborhood gradient value, and the initial growth seed point is determined according to the area of the initial growth point of the lung lesion; pixel grey level constraints and growth distance constraints are obtained according to the initial growth seed point, a lung lesion area is determined from the pixel grey level constraints and the growth distance constraints through an area growth method; boundaries of all layers of the lung lesion area are obtained according to the lug lesion area, boundary pixel points of adjacent layers in the lung lesion area are obtained in the central points of the boundaries of all the layers of the lung lesion area in the preset direction, the average distance difference value is obtained according to the boundary pixel points of the adjacent layers and the central point of the lung lesion area, and the pixel points exceeding the average distance difference value are horizontally slide to obtain segmentation images of the lung lesion tissue.
Owner:INST OF AUTOMATION CHINESE ACAD OF SCI

A lung anatomy location positioning algorithm based on a deep learning technology

The invention discloses a lung anatomy position positioning algorithm based on a deep learning technology, which can accurately and quickly divide lung CT, and can simply, quickly and accurately realize automatic segmentation of lung lobes based on lung CT images, thereby realizing the anatomy position positioning of lung lesions. Compared with a traditional segmentation method, the method has theoutstanding advantages that (1) the process is simple, and the end-to-end segmentation mode does not need to pay attention to other processes; (2) the multi-stage and multi-output network architecture controls the network in different stages, so that the segmentation effect is better, and the segmentation precision can be ensured to the maximum extent through a semantic-based segmentation mode; and (3) the generalization ability is strong, and the data in the training process is enhanced, so that the model can learn different and diverse data, namely, the generalization ability of the segmentation model is ensured, meanwhile, the risk of over-fitting is also avoided to a certain extent, and the geometric deformation and illumination influence of CT (computed tomography) are insensitive when lung lobe division is performed on different CT.
Owner:成都蓝景信息技术有限公司

Preparation method, formula and use method of bovine mycoplasma pneumonia inactivated vaccine

The invention provides a preparation method, a formula and a use method of a bovine mycoplasma pneumonia inactivated vaccine. The preparation method of the bovine mycoplasma pneumonia inactivated vaccine comprises the following steps: 1, selecting diseased cattle which naturally infect mycoplasma pneumonia and is dying, taking diseased lungs, lymph glands and spleens to homogenize and removing precipitates and grease through filtering and centrifugation to obtain an antigen solution; 2, adding formaldehyde into the antigen solution to inactivate for 72 hours, adding 1,000 units of penicillin and 1,000 units of streptomycin into the antigen solution per millimeter and uniformly mixing to obtain an inactivated antigen solution; 3, mixing the inactivated antigen solution with an aluminum hydroxide adjuvant according to the proportion of 4:1 to obtain the inactivated vaccine. The vaccine prepared by the preparation method is safe in application, strong in pertinence and indeed in immune protection effect on mycoplasma causing bovine pleuropneumonia by infection, the lung lesion score of the infected cattle can be obviously reduced, the material weight ratio is improved, and the good effects of prevention and disease control can be achieved.
Owner:福清市默克兽医院

A kind of traditional Chinese medicine composition for treating lung diseases

The invention relates to a traditional Chinese medicine prescription for treating pulmonary diseases, which comprises lapis chloriti, roasted ephedra, almond, schisandra, snakegourd peel and roasted licorice. Experiments prove that the traditional Chinese medicine prescription can obviously improve the pulmonary lesion and inflammatory reaction of a model rat with the chronic obstructive pulmonary disease at the acute exacerbation, so as to obviously reduce the contents of main inflammatory markers in the serum of the model rat, and simultaneously can promote the trachea repair of the model rat so as to prevent the occurrence and development of trachea inflammation. Clinical researches show that the traditional Chinese medicine prescription has a good effect and a high effect taking speed when being used for treating empirical pulmonary diseases, such as accumulation of pathogenic heat in the lung and obstruction of the lung by phlegm; the good effect can be achieved within 3-10 days, and the total effective rate reaches 96.6%; the traditional Chinese medicine prescription especially has good curative effects on chronic intractable pulmonary diseases induced by pathogenic heat and stubborn phlegm; the traditional Chinese medicine prescription does not have toxic or side effects; and the pulmonary diseases can not recur.
Owner:NANJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products